 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
( E4 \( q; J' z7 S0 E: u 8 M8 ]6 W* t; I/ X7 _4 W- F g
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.4 r1 Q' i, d r* Q6 d v; l; N6 ^
9 h# w, q# w* ]" b- |BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
) u" Y4 [4 S! U3 x& y ! r3 u6 |0 T0 g+ h- }8 U6 J
5 W: `4 D7 k7 |EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.2 C0 B* ^ I% f. [! E
- n& L6 Y5 F, o& E. V
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."! z1 n1 F; j+ i5 h
( |" x$ a( F( iThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.: Q& [( i; c, r1 N9 f( S* U5 b
8 R* g8 c7 c$ s0 JIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
, z8 L4 o9 n* g- Q0 J+ N1 S ~, Y
+ q+ z* l: ?1 H, t. eIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
3 k7 h, f6 i# _5 x1 G0 `+ X. N3 Z+ v4 w: P, C y
"As a scientist, it's one of the highlights of my CAREER," Shan said.7 e! e' L7 V% u5 A% Y) u
1 B# R! j7 ]" m/ e; v; `* i
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."; q2 j1 }0 C1 m8 h' Q
4 O4 [- O0 ~3 lIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
0 E' t- n: I% _# y" n9 c
2 J1 Z8 z- f- H! k' b4 k( _6 VGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.7 U" j0 I7 Y* T1 `
( S& ]7 N; _0 D) G) \% b5 R
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.6 ^+ J- H( {7 M/ I! O2 N* h, I
$ V' Q6 Y/ o7 G: _7 z1 q- _7 y, Q) L
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
- Y ~, [# l3 K2 [
发表于 2015-2-28 19:45
